| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
89,888 |
82,992 |
$3.07M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
16,207 |
16,161 |
$1.27M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16,346 |
16,298 |
$1.21M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12,719 |
12,627 |
$1.08M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
80,415 |
38,141 |
$830K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,072 |
14,562 |
$734K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
10,038 |
9,833 |
$716K |
| 99429 |
|
16,074 |
16,034 |
$504K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25,096 |
24,581 |
$339K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
29,839 |
22,724 |
$233K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,044 |
4,966 |
$211K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,881 |
6,790 |
$161K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,642 |
5,747 |
$157K |
| 99050 |
|
10,301 |
10,036 |
$135K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,338 |
4,247 |
$124K |
| 99383 |
|
1,331 |
1,330 |
$111K |
| 90461 |
|
18,795 |
15,753 |
$89K |
| 99381 |
|
1,197 |
1,183 |
$84K |
| 99384 |
|
759 |
753 |
$69K |
| 83655 |
|
6,711 |
6,690 |
$68K |
| 99382 |
|
667 |
666 |
$56K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
439 |
438 |
$36K |
| 96160 |
|
15,589 |
15,472 |
$32K |
| 99000 |
|
3,262 |
3,114 |
$30K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
506 |
503 |
$28K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,413 |
2,322 |
$23K |
| 99460 |
|
290 |
288 |
$21K |
| 0071A |
|
482 |
480 |
$18K |
| 0001A |
|
448 |
440 |
$17K |
| 87807 |
|
1,391 |
1,377 |
$15K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
236 |
234 |
$13K |
| 0072A |
|
302 |
301 |
$11K |
| 0002A |
|
262 |
261 |
$10K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
28 |
27 |
$10K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
53 |
52 |
$7K |
| 92551 |
|
7,552 |
7,447 |
$7K |
| 81002 |
|
2,188 |
2,122 |
$6K |
| 0051A |
|
145 |
145 |
$5K |
| 99080 |
|
186 |
185 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
61 |
51 |
$4K |
| 95117 |
|
496 |
168 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
295 |
282 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
225 |
219 |
$3K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
12 |
12 |
$3K |
| 85018 |
|
1,688 |
1,672 |
$3K |
| 0052A |
|
67 |
67 |
$2K |
| 88720 |
|
607 |
507 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
52 |
51 |
$2K |
| 96380 |
|
97 |
97 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
34 |
33 |
$2K |
| 0054A |
|
41 |
41 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
109 |
93 |
$1K |
| 81025 |
|
145 |
144 |
$1K |
| S9441 |
Asthma education, non-physician provider, per session |
79 |
78 |
$971.34 |
| 0081A |
|
31 |
31 |
$798.50 |
| 0073A |
|
18 |
18 |
$600.00 |
| 90677 |
|
1,572 |
1,568 |
$515.46 |
| 97169 |
|
54 |
52 |
$510.00 |
| 96127 |
|
1,036 |
984 |
$245.66 |
| 94760 |
|
209 |
205 |
$237.68 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
39 |
39 |
$204.79 |
| 90688 |
|
1,501 |
1,495 |
$85.80 |
| 90715 |
|
2,242 |
2,219 |
$31.50 |
| 90671 |
|
951 |
948 |
$26.58 |
| 99174 |
|
229 |
226 |
$21.00 |
| 99173 |
|
8,022 |
7,908 |
$14.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
214 |
211 |
$9.49 |
| 90686 |
|
8,920 |
8,882 |
$0.36 |
| 90381 |
|
43 |
43 |
$0.18 |
| 90623 |
|
37 |
37 |
$0.14 |
| 90620 |
|
3,036 |
3,003 |
$0.14 |
| 90734 |
|
4,840 |
4,781 |
$0.09 |
| 91300 |
|
715 |
673 |
$0.03 |
| 90651 |
|
6,856 |
6,798 |
$0.02 |
| 90670 |
|
6,484 |
6,457 |
$0.00 |
| 90648 |
|
6,536 |
6,513 |
$0.00 |
| 90633 |
|
5,666 |
5,648 |
$0.00 |
| 90710 |
|
4,923 |
4,900 |
$0.00 |
| 90700 |
|
1,826 |
1,820 |
$0.00 |
| 90707 |
|
125 |
125 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
15 |
14 |
$0.00 |
| 91308 |
|
48 |
41 |
$0.00 |
| 90713 |
|
33 |
33 |
$0.00 |
| 90680 |
|
4,915 |
4,902 |
$0.00 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
360 |
340 |
$0.00 |
| 90716 |
|
137 |
137 |
$0.00 |
| 90696 |
|
2,087 |
2,076 |
$0.00 |
| 36416 |
|
757 |
722 |
$0.00 |
| 91307 |
|
880 |
840 |
$0.00 |
| 90723 |
|
4,143 |
4,129 |
$0.00 |
| 90698 |
|
1,318 |
1,314 |
$0.00 |
| 91305 |
|
411 |
407 |
$0.00 |
| 90744 |
|
25 |
25 |
$0.00 |